C. Mallen

First name
C.
Middle name
D.
Last name
Mallen
Hancock, A. T., Mallen, C. D., Muller, S., Belcher, J., Roddy, E., Helliwell, T., & Hider, S. L. (2014). Risk of vascular events in patients with polymyalgia rheumatica. Cmaj. http://doi.org/10.1503/cmaj.140266
Muller, S., Hider, S. L., Belcher, J., Helliwell, T., & Mallen, C. D. (2014). Is cancer associated with polymyalgia rheumatica? A cohort study in the General Practice Research Database. Ann Rheum Dis. http://doi.org/10.1136/annrheumdis-2013-203465
Clarson, L. E., Hider, S. L., Belcher, J., Heneghan, C., Roddy, E., & Mallen, C. D. (2015). Increased risk of vascular disease associated with gout: a retrospective, matched cohort study in the UK clinical practice research datalink. Ann Rheum Dis. http://doi.org/10.1136/annrheumdis-2014-205252
Muller, S., Hider, S. L., Raza, K., Stack, R. J., Hayward, R. A., & Mallen, C. D. (2015). An algorithm to identify rheumatoid arthritis in primary care: a Clinical Practice Research Datalink study. BMJ Open. http://doi.org/10.1136/bmjopen-2015-009309
Abhishek, A., Doherty, M., Kuo, C. F., Mallen, C. D., Zhang, W., & Grainge, M. J. (2017). Rheumatoid arthritis is getting less frequent-results of a nationwide population-based cohort study. Rheumatology (Oxford). http://doi.org/10.1093/rheumatology/kew468
Roddy, E., Muller, S., Paskins, Z., Hider, S. L., Blagojevic-Bucknall, M., & Mallen, C. D. (2017). Incident acute pseudogout and prior bisphosphonate use: Matched case-control study in the UK-Clinical Practice Research Datalink. Medicine (Baltimore). http://doi.org/10.1097/md.0000000000006177
Clarson, L. E., Hider, S. L., Belcher, J., Roddy, E., & Mallen, C. D. (2017). Factors Influencing Allopurinol Initiation in Primary Care. Ann Fam Med. http://doi.org/10.1370/afm.2137
Nakafero, G., Grainge, M. J., Myles, P. R., Mallen, C. D., Zhang, W., Doherty, M., et al. (2018). Predictors and temporal trend of flu vaccination in auto-immune rheumatic diseases in the UK: a nationwide prospective cohort study. Rheumatology (Oxford). http://doi.org/10.1093/rheumatology/key156
Roughley, M., Sultan, A. A., Clarson, L., Muller, S., Whittle, R., Belcher, J., et al. (2018). Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study. Arthritis Res Ther. http://doi.org/10.1186/s13075-018-1746-1
Sultan, A. A., Whittle, R., Muller, S., Roddy, E., Mallen, C. D., Bucknall, M., et al. (2018). Risk of fragility fracture among patients with gout and the effect of urate-lowering therapy. Cmaj. http://doi.org/10.1503/cmaj.170806